IN RE Talis Biomedical Securities Litigation

Good Law
United States District Court, Northern District of CaliforniaJune 3, 20223:22-cv-00105California2,035 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 JOHN MODRAK, et al., Case No. 22-cv-00105-SI Plaintiffs, Related Case No. 22-cv-01039-SI

v. ORDER GRANTING MOTIONS TO

CONSOLIDATE CASES AND

TALIS BIOMEDICAL CORPORATION, et GRANTING MOTIONS FOR al., APPOINTMENT OF CO-LEAD PLAINTIFFS AND CO-LEAD Defendants. COUNSEL 12 Re: Dkt. Nos. 19, 23, 27, 30

14 On June 3, 2022, the Court held the continued hearing on plaintiffs’ motions to consolidate 15 and for appointment of lead plaintiff and lead counsel. For the reasons set forth below, the Court 16 GRANTS the motions to consolidate and GRANTS the revised proposal for appointment of co-lead 17 plaintiffs and co-lead counsel. The parties shall file a stipulation regarding the schedule for the filing of the complaint and motion practice no later than June 13, 2022. 19 BACKGROUND On January 7, 2022, and February 18, 2022, plaintiffs filed two securities class…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.